Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2007
09/05/2007CN101029047A Isocoumarin compound with antineoplastic and antiulcer activities
09/05/2007CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods
09/05/2007CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives
09/05/2007CN100335478C Chemokine receptor binding heterocyclic compounds
09/04/2007US7265152 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
09/04/2007US7265144 Mixture with other active materials; controlling glucose metabolism
09/04/2007US7265140 E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria
09/04/2007US7265138 inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis
09/04/2007US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
09/04/2007US7265127 Imidazo[1,2-a]pyridine derivatives, especially N-(2-(8-(3-aminocarbonyl-2-pyridyloxy)imidazo[1,2-a]pyrid-3-yl)-1,1-dimethylethyl)-3-(o-isoxazol-3-ylphenoxy)-2-hydroxypropylamine; treating type-2 diabetes and obesity
09/04/2007US7265122 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
09/04/2007US7265120 Pyrazine derivatives and pharmaceutical use thereof
09/04/2007US7265116 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease
09/04/2007US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis
09/04/2007US7265112 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/04/2007US7265110 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders
09/04/2007US7265109 Thiazole derivatives
09/04/2007US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders
09/04/2007US7265102 Substituted pyrazoles
09/04/2007US7265093 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity
09/04/2007US7264891 Stability, efficiency and color purity
09/04/2007CA2258044C Muscarinic antagonists
08/2007
08/30/2007WO2007098356A1 Congeners of milnacipran as monoamine re-uptake
08/30/2007WO2007098214A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007WO2007098169A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007WO2007098142A2 Oxazole ketones as modulators of fatty acid amide hydrolase
08/30/2007WO2007097937A1 Pyrrolidine derivatives as erk inhibitors
08/30/2007WO2007097403A1 Remedy or preventive for digestive ulcer
08/30/2007WO2007097276A1 Pyrrole derivative or salt thereof
08/30/2007WO2007097197A1 Amide derivative or salt thereof
08/30/2007WO2007096576A1 Herbicidal isoxazoline compounds
08/30/2007WO2007096351A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
08/30/2007WO2007096186A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
08/30/2007WO2007095812A1 Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof
08/30/2007WO2007095784A1 The triazolyl-containing oxazolidinone derivatives, the preparation method and the uses thereof
08/30/2007WO2007071455B1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
08/30/2007WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds
08/30/2007WO2007064566A3 Heterocycle-substituted 3-alkyl azetidine derivatives
08/30/2007WO2007058338A9 Oxazole compound and pharmaceutical composition
08/30/2007WO2007034326A3 Imidazole compounds for the treatment of neurological disorders
08/30/2007WO2006015854A3 Azetidine derivatives as ccr-3 receptor antagonists
08/30/2007US20070203342 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine
08/30/2007US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
08/30/2007US20070203201 Substituted anthranilamides for controlling invertebrate pests
08/30/2007US20070203194 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
08/30/2007US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/30/2007US20070203192 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety
08/30/2007US20070203187 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
08/30/2007US20070203179 Azadecalin Glucocorticoid Receptor Modulators
08/30/2007US20070203156 Oxazole ketones as modulators of fatty acid amide hydrolase
08/30/2007US20070203137 New Salt
08/30/2007US20070203134 Benzimidazole Acetonitriles
08/30/2007US20070203131 Bis-aryl sulfonamides
08/30/2007US20070203130 sodium channel and calcium channel inhibitors, such as 2-Indol-1-yl-N-[5-(thiazol-2-ylsulfamoyl)-naphthalen-1-yl]-propionamide, used as analgesics or for the treatment of neurodegenerative disorders, anxiety, depression, arrhythmia, ataxia, multiple sclerosis, irritable bowel syndrome or incontinence
08/30/2007US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use
08/30/2007US20070203128 Modulation of Pathogenicity
08/30/2007US20070203124 Therapeutic Piperazines
08/30/2007US20070203121 Substituted indole compounds, their preparation and use in medicaments
08/30/2007US20070203072 Hcv Ns-3 Serine Protease Inhibitors
08/30/2007US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors
08/30/2007US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
08/30/2007CA2643983A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007CA2643963A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007CA2643272A1 Gent for treating or preventing digestive ulcer
08/30/2007CA2642762A1 Pyrrolidine derivatives as erk inhibitors
08/30/2007CA2642619A1 Pyrrole derivative or salt thereof
08/30/2007CA2642610A1 Amide derivative or salt thereof
08/30/2007CA2640962A1 Herbicidal isoxazoline compounds
08/30/2007CA2638095A1 New compounds
08/29/2007EP1826208A1 Cyanine compound, optical recording material utilizing the compound, and optical recording medium
08/29/2007EP1824844A1 Pyrazine dicarboxamides and the use thereof
08/29/2007EP1824843A2 Inhibitors of protein kinases
08/29/2007EP1824838A1 Novel compounds
08/29/2007EP1824823A1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
08/29/2007EP1824822A2 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors
08/29/2007EP1824490A1 Piperazinyl-pyridine analogues
08/29/2007EP1824489A2 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
08/29/2007EP1824480A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
08/29/2007EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins
08/29/2007EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia
08/29/2007EP1590344A4 Anti-cancer medicaments
08/29/2007EP1562938B1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/29/2007EP1549643B1 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
08/29/2007EP1517899B1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
08/29/2007EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor
08/29/2007EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
08/29/2007CN101027298A Benzoxazine compounds derivated from phenolphtalein having flame-retardant properties and a process for their preparation
08/29/2007CN101027297A Macrocyclic beta-secretase inhibitors
08/29/2007CN101027296A Oxazolidinone compounds and compositions and methods related thereto
08/29/2007CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
08/29/2007CN101027292A Compounds, compositions containing them, preparation thereof and uses thereof
08/29/2007CN101027286A Indozolone derivatives as 11b-HSD1 inhibitors
08/29/2007CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/29/2007CN101024627A Nitrogen-containing aromatic derivatives
08/29/2007CN101024626A Intermediate synthesizing compound for preparing atorvastatin calcium
08/29/2007CN100334077C Benzimidazole derivatives and their use as GNRH antagonists
08/28/2007US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds
08/28/2007US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1
08/28/2007US7262303 Process for the production of chiral propionic acid derivatives
08/28/2007US7262301 Zinc-chelating ratiometric fluorescent probes and related methods